Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32.09%9.74B | 30.83%33.27B | 28.96%7.38B | 32.31%25.43B | 29.60%7.01B | 30.55%6.65B | 35.10%6.05B | 34.95%5.72B | 33.65%19.22B | 39.62%5.41B |
| Cost of revenue | 45.44%1.86B | 33.13%5.91B | 27.76%1.28B | 40.76%4.44B | 31.28%1.17B | 37.95%1.19B | 54.83%1.07B | 42.37%1B | 11.01%3.15B | 28.60%891.13M |
| Gross profit | 29.29%7.88B | 30.34%27.36B | 29.21%6.1B | 30.66%20.99B | 29.27%5.84B | 29.04%5.46B | 31.49%4.98B | 33.47%4.72B | 39.23%16.07B | 42.02%4.52B |
| Operating expense | 29.36%7.61B | -8.95%26.75B | -13.39%5.88B | 22.48%29.38B | -6.06%7.26B | 22.08%7.7B | 45.47%7.62B | 44.32%6.79B | 64.49%23.99B | 86.68%7.73B |
| Operating profit | 27.24%271.68M | 107.29%610.97M | 110.29%213.52M | -5.90%-8.39B | 55.66%-1.43B | -7.93%-2.25B | -81.94%-2.64B | -77.05%-2.07B | -160.28%-7.92B | -234.30%-3.22B |
| Net non-operating interest income (expenses) | -22.53%-10.85M | -176.83%-62.85M | -3,413.10%-8.85M | -182.92%-22.7M | -2,657.97%-15.22M | -1,402.15%-5.59M | 35.76%-1.64M | 94.46%-252K | -4,763.64%-8.03M | 86.71%-552K |
| Non-operating interest income | 950.75%20.89M | 1,999.39%17.32M | --1.99M | -86.84%825K | -3.63%770K | -104.19%-184K | ---- | ---- | 5.38%6.27M | --799K |
| Non-operating interest expense | 192.75%31.74M | 287.57%76.07M | 4,201.98%10.84M | 47.50%19.63M | 3,231.40%12.09M | 13.48%5.4M | -48.29%1.88M | -94.46%252K | 203.47%13.31M | -85.03%363K |
| Total other finance cost | ---- | 5.08%4.1M | ---- | 294.84%3.9M | ---- | ---- | ---- | ---- | -42.89%988K | ---- |
| Net investment income | -32.32%-11.5M | 26.87%-13.05M | 26.80%-8.69M | -32.36%-17.84M | 109.40%272K | 3,400.00%462K | -177.54%-6.7M | -45.59%-11.88M | 50.88%-13.48M | 70.14%-2.89M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -8.18M | -68.47%-49.25M | 74.10%-29.23M | 217.40%2.11M | 54.80%-29.3M | -1,828.29%-112.86M | -1.79M | |||
| Income from associates and other participating interests | -3.58%-318K | -1.17M | -307K | 0 | ||||||
| Special income (charges) | 82.18%23.39M | 102.26%32.4M | 110.03%12.84M | 66.27%-1.44B | 98.13%-23.92M | 82.71%-139.15M | -953.33%-1.14B | 93.80%-128.06M | 53.81%-4.26B | 85.94%-1.28B |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 | 11,069.68%45.68M | --0 |
| Less:Other special charges | -82.18%-23.39M | 12.56%-32.4M | -327.43%-12.84M | -465.45%-37.05M | -370.75%-7.84M | ---26.2M | --0 | 68.10%-3M | -7.76%-6.55M | 12.34%2.9M |
| Less:Write off | ---- | --0 | --0 | -65.07%1.47B | -97.51%31.76M | -81.15%165.35M | 953.03%1.14B | -93.30%131.06M | -54.27%4.22B | -85.97%1.28B |
| Other non-operating income (expenses) | -211.60%-99.67M | 45.36%-100.81M | 25.43%-31.99M | -901.65%-184.51M | -1,093.63%-26.35M | -101.70%-6.88M | -2,054.75%-108.38M | -239.62%-42.9M | -89.07%-18.42M | 125.65%2.65M |
| Income before tax | -6.78%164.55M | 104.13%416.24M | 107.82%176.52M | 18.26%-10.08B | 66.88%-1.49B | 17.87%-2.43B | -141.55%-3.9B | 30.79%-2.26B | -0.22%-12.33B | 55.38%-4.5B |
| Income tax | 52.48%10.05M | -2,061.96%-953.79M | -59.10%6.59M | 20,271.78%48.61M | 315.17%25.02M | 21.96%4.08M | -11.43%3.4M | 283.66%16.11M | 99.97%-241K | 98.35%-11.63M |
| Net income | -9.08%154.5M | 113.53%1.37B | 107.47%169.93M | 17.87%-10.13B | 66.24%-1.51B | 17.82%-2.43B | -141.19%-3.91B | 30.39%-2.27B | -6.20%-12.33B | 52.14%-4.48B |
| Net income continuous operations | -9.08%154.5M | 113.53%1.37B | 107.47%169.93M | 17.87%-10.13B | 66.24%-1.51B | 17.82%-2.43B | -141.19%-3.91B | 30.39%-2.27B | -6.20%-12.33B | 52.14%-4.48B |
| Noncontrolling interests | 0 | 0 | 148.06%25.24M | 0 | 0 | 10.76M | 14.48M | 10.17M | 10.17M | |
| Net income attributable to the company | -9.08%154.5M | 113.50%1.37B | 107.43%169.93M | 17.73%-10.15B | 66.32%-1.51B | 17.82%-2.43B | -141.85%-3.92B | 29.94%-2.29B | -6.28%-12.34B | 52.04%-4.49B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -9.08%154.5M | 113.50%1.37B | 107.43%169.93M | 17.73%-10.15B | 66.32%-1.51B | 17.82%-2.43B | -141.85%-3.92B | 29.94%-2.29B | -6.28%-12.34B | 52.04%-4.49B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -10.00%2.61 | 113.35%23.28 | 107.34%2.9 | 19.11%-174.43 | 66.95%-25.83 | 19.36%-41.66 | -137.92%-67.45 | 31.29%-39.49 | -3.56%-215.64 | 53.45%-78.16 |
| Diluted earnings per share | -10.34%2.6 | 113.24%23.1 | 107.34%2.9 | 19.11%-174.43 | 66.92%-25.8556 | 19.35%-41.6661 | -137.41%-67.45 | 31.29%-39.49 | -3.56%-215.64 | 53.45%-78.16 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |